Carbonic anhydrase activators: Kinetic and X-ray crystallographic study for the interaction of d- and l-tryptophan with the mammalian isoforms I–XIV

Bioorganic & Medicinal Chemistry
2008.0

Abstract

An activation study of mammalian carbonic anhydrase (CA, EC 4.2.1.1) isoforms I-XIV with D- and L-tryptophan has been performed both by means of kinetic and X-ray crystallographic techniques. These compounds show a time dependent activity against isozyme CA II, with activation constants of 1.13 microM for L-Trp and 0.37 microM for D-Trp, respectively, after 24 h of incubation between enzyme and activator. The high resolution X-ray crystal structure of the hCA II-D-Trp adduct revealed the activator to bind in a totally unprecedented way to the enzyme active site as compared to histamine, L-/D-Phe, L-/D-His or L-adrenaline. D-Trp is anchored at the edge of the CA II active site entrance, strongly interacting with amino acid residues Asp130, Phe131 and Gly132 as well as with a loop of a second symmetry related protein molecule from the asymmetric unit, by means of hydrogen bonds and several weak van der Waals interactions involving Glu234, Gly235, Glu236 and Glu238. Thus, a second activator binding site (B) within the CA II cavity has been detected, where only D-Trp was shown so far to bind, in addition to the activator binding site A, in which histamine, L-/D-Phe, and L-/D-His are bound. These findings explain the strong affinity of D-Trp for CA II and may be useful for designing novel classes of CA activators by using this compound as lead molecule.

Knowledge Graph

Similar Paper

Carbonic anhydrase activators: Kinetic and X-ray crystallographic study for the interaction of d- and l-tryptophan with the mammalian isoforms I–XIV
Bioorganic & Medicinal Chemistry 2008.0
Carbonic anhydrase activators: X-ray crystal structure of the adduct of human isozyme II with l-histidine as a platform for the design of stronger activators
Bioorganic & Medicinal Chemistry Letters 2005.0
Carbonic anhydrase activators: l-Adrenaline plugs the active site entrance of isozyme II, activating better isoforms I, IV, VA, VII, and XIV
Bioorganic & Medicinal Chemistry Letters 2007.0
Carbonic anhydrase activators: The first X-ray crystallographic study of an adduct of isoform I
Bioorganic & Medicinal Chemistry Letters 2006.0
Carbonic anhydrase activators: Activation of the human cytosolic isozyme III and membrane-associated isoform IV with amino acids and amines
Bioorganic & Medicinal Chemistry Letters 2008.0
Carbonic anhydrase activators: Activation of isozyme XIII with amino acids and amines
Bioorganic & Medicinal Chemistry Letters 2006.0
Carbonic anhydrase activators: Activation of the human tumor-associated isozymes IX and XII with amino acids and amines
Bioorganic & Medicinal Chemistry 2008.0
Carbonic anhydrase activators: Activation of the human isoforms VII (cytosolic) and XIV (transmembrane) with amino acids and amines
Bioorganic & Medicinal Chemistry Letters 2007.0
Carbonic anhydrase activators: The first activation study of the human secretory isoform VI with amino acids and amines
Bioorganic & Medicinal Chemistry 2007.0
Carbonic anhydrase activators. Activation of the membrane-associated isoform XV with amino acids and amines
Bioorganic & Medicinal Chemistry Letters 2009.0